[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100546697":3},{"organization":4,"armGroups":7,"interventions":17,"overallOfficials":23,"centralContacts":28,"locations":38,"responsibleParty":176,"collaborators":178,"id":201,"slug":202,"hasResults":203,"nctId":204,"briefTitle":205,"officialTitle":205,"acronym":206,"eligibilityCriteria":207,"healthyVolunteers":203,"sex":208,"minAge":209,"maxAge":11,"enrollmentInfo":210,"targetDuration":11,"studyType":213,"phases":214,"briefSummary":216,"conditions":217,"keywords":221,"overallStatus":41,"whyStopped":11,"lastUpdateSubmitDate":227,"lastUpdatePostDateStruct":228,"startDateStruct":231,"completionDateStruct":233,"leadSponsor":235,"locationsCount":236},{"fullName":5,"class":6},"Sykehuset Telemark","OTHER_GOV",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"1-2 fractions of 8 Gy (Gray)","ACTIVE_COMPARATOR",null,[13],"Radiation: Palliative radiotherapy",{"label":15,"type":10,"description":11,"interventionNames":16},"5 fractions of 5 Gy (Gray)",[13],[18],{"type":19,"name":20,"description":21,"armGroupLabels":22,"otherNames":11},"RADIATION","Palliative radiotherapy","Hypofractionated radiotherapy",[9,15],[24],{"name":25,"affiliation":26,"role":27},"Harald Ragnum, MD,PhD","Telemark Hospital Trust","STUDY_CHAIR",[29,34],{"name":30,"role":31,"phone":32,"phoneExt":11,"email":33},"Kjersti Skipar, MD","CONTACT","+47 98444114","kjeski@sthf.no",{"name":35,"role":31,"phone":36,"phoneExt":11,"email":37},"Harald Ragnum, MD, PhD","+47 90792571","harrag@sthf.no",[39,54,66,78,90,102,114,126,140,152,164],{"facility":40,"status":41,"city":42,"state":11,"zip":11,"country":43,"countryCode":44,"cosmosGeoPoint":45,"geoPoint":50,"contacts":51},"Helse Møre og Romsdal","RECRUITING","Ålesund","Norway","NO",{"type":46,"coordinates":47},"Point",[48,49],6.15492,62.47225,{"lat":49,"lon":48},[52],{"name":53,"role":31,"phone":11,"phoneExt":11,"email":11},"Cecilie S Nordstrand",{"facility":55,"status":41,"city":56,"state":11,"zip":11,"country":43,"countryCode":44,"cosmosGeoPoint":57,"geoPoint":61,"contacts":62},"Haukeland universitetssykehus","Bergen",{"type":46,"coordinates":58},[59,60],5.32415,60.39299,{"lat":60,"lon":59},[63],{"name":64,"role":31,"phone":11,"phoneExt":11,"email":65},"Christian Ekanger","christian.ekanger@helse-bergen.no",{"facility":67,"status":41,"city":68,"state":11,"zip":11,"country":43,"countryCode":44,"cosmosGeoPoint":69,"geoPoint":73,"contacts":74},"Nordlandssykehuset Bodø","Bodø",{"type":46,"coordinates":70},[71,72],14.37513,67.28267,{"lat":72,"lon":71},[75],{"name":76,"role":31,"phone":11,"phoneExt":11,"email":77},"Carsten Nieder","carsten.Nieder@nordlandssykehuset.no",{"facility":79,"status":41,"city":80,"state":11,"zip":11,"country":43,"countryCode":44,"cosmosGeoPoint":81,"geoPoint":85,"contacts":86},"Vestre Viken HF","Drammen",{"type":46,"coordinates":82},[83,84],10.20449,59.74389,{"lat":84,"lon":83},[87],{"name":88,"role":31,"phone":11,"phoneExt":11,"email":89},"Elin Høie Østrem","Elin.Hoie.Ostrem@vestreviken.no",{"facility":91,"status":41,"city":92,"state":11,"zip":11,"country":43,"countryCode":44,"cosmosGeoPoint":93,"geoPoint":97,"contacts":98},"Sykehuset Innlandet HF","Gjøvik",{"type":46,"coordinates":94},[95,96],10.69155,60.79574,{"lat":96,"lon":95},[99],{"name":100,"role":31,"phone":11,"phoneExt":11,"email":101},"Liv-Ellen Giske","Liv.Ellen.Giske@sykehuset-innlandet.no",{"facility":103,"status":41,"city":104,"state":11,"zip":11,"country":43,"countryCode":44,"cosmosGeoPoint":105,"geoPoint":109,"contacts":110},"Sørlandet sykehus HF","Kristiansand",{"type":46,"coordinates":106},[107,108],7.9956,58.14671,{"lat":108,"lon":107},[111],{"name":112,"role":31,"phone":11,"phoneExt":11,"email":113},"Christoph Evers","Christoph.Evers@sshf.no",{"facility":115,"status":41,"city":116,"state":11,"zip":11,"country":43,"countryCode":44,"cosmosGeoPoint":117,"geoPoint":121,"contacts":122},"Oslo Universitetssykehus","Oslo",{"type":46,"coordinates":118},[119,120],10.74609,59.91273,{"lat":120,"lon":119},[123],{"name":124,"role":31,"phone":11,"phoneExt":11,"email":125},"Marianne G Guren","Marianne.Gronlie.Guren@ous-hf.no",{"facility":127,"status":41,"city":128,"state":11,"zip":11,"country":43,"countryCode":44,"cosmosGeoPoint":129,"geoPoint":133,"contacts":134},"Sykehuset Telemark HF","Skien",{"type":46,"coordinates":130},[131,132],9.60897,59.20962,{"lat":132,"lon":131},[135,137],{"name":136,"role":31,"phone":11,"phoneExt":11,"email":33},"Kjersti Skipar",{"name":138,"role":31,"phone":11,"phoneExt":11,"email":139},"Harald B Ragnum","Harrag@sthf.no",{"facility":141,"status":41,"city":142,"state":11,"zip":11,"country":43,"countryCode":44,"cosmosGeoPoint":143,"geoPoint":147,"contacts":148},"Stavanger Universitetssykehus","Stavanger",{"type":46,"coordinates":144},[145,146],5.73332,58.97005,{"lat":146,"lon":145},[149],{"name":150,"role":31,"phone":11,"phoneExt":11,"email":151},"Kjersti Ødegaard","kjersti.odegaard@sus.no",{"facility":153,"status":41,"city":154,"state":11,"zip":11,"country":43,"countryCode":44,"cosmosGeoPoint":155,"geoPoint":159,"contacts":160},"Universitetssykehuset i Nord-Norge","Tromsø",{"type":46,"coordinates":156},[157,158],18.95508,69.6489,{"lat":158,"lon":157},[161],{"name":162,"role":31,"phone":11,"phoneExt":11,"email":163},"Lise Balteskard","Lise.Balteskard@unn.no",{"facility":165,"status":41,"city":166,"state":11,"zip":11,"country":43,"countryCode":44,"cosmosGeoPoint":167,"geoPoint":171,"contacts":172},"St. Olavs Hospital HF","Trondheim",{"type":46,"coordinates":168},[169,170],10.39506,63.43049,{"lat":170,"lon":169},[173],{"name":174,"role":31,"phone":11,"phoneExt":11,"email":175},"Hanne Tøndel","Hanne.Tondel@stolav.no",{"type":177,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR",[179,182,184,186,188,190,192,193,195,197,199],{"name":180,"class":181},"Nordlandssykehuset HF","OTHER",{"name":183,"class":181},"Møre og Romsdal Hospital Trust",{"name":185,"class":6},"Helse Stavanger HF",{"name":187,"class":181},"Hospital of Southern Norway Trust",{"name":189,"class":181},"Oslo University Hospital",{"name":191,"class":181},"Vestre Viken Hospital Trust",{"name":91,"class":181},{"name":194,"class":181},"St. Olavs Hospital",{"name":196,"class":181},"Haukeland University Hospital",{"name":198,"class":181},"University Hospital of North Norway",{"name":200,"class":181},"South-Eastern Norway Regional Health Authority","100546697","palliative-radiotherapy-in-symptomatic-pelvic-soft-tissue-tumors-100546697",false,"NCT06398314","Palliative Radiotherapy in Symptomatic Pelvic Soft Tissue Tumors","PALLSOFT","Inclusion Criteria:\n\n* Patients unsuitable for curative treatment due to either advanced disease or medical contradictions (i.e comorbidity, old age, poor general condition)\n* Histologically verified primary cancer originated from gastrointestinal, urological or gynecological organs (histological verification can be performed on other lesions than the symptomatic pelvic tumor)\n* Primary, residual, recurrent or metastatic pelvic tumor from the above-mentioned cancers not amenable for curative treatment\n* Tumor-related symptoms including within the 5 defined categories pain, bleeding, bowel\u002Flower urinary\u002Fvaginal dysfunction\n* Considered candidate for palliative radiotherapy according to both study arms\n* Patient reported severity of symptoms ≥4 on a NRS- scale of 0-10\n* ≥18 years of age\n* Speaks and understands Norwegian or English\n* Ability to understand and willing to sign a written informed consent\n* ECOG performance status 0-3\n* Expected survival \\> 12 weeks\n* Able to pause systemic cancer treatment for one week prior to, during, and one week after the radiotherapy treatment\n* Women of childbearing potential (WOCBP) should have a negative highly sensitive serum pregnancy test within 72 hours prior to study intervention. WOCBP must agree to the use of highly effective birth control methods or abstain from heterosexual sexual activity from randomization and until completed study intervention\n\nExclusion Criteria:\n\n* Neuroendocrine histology of any kind\n* Sarcoma or sarcomal components in the histology\n* Tumors that originate from bony metastases without a soft tissue component\n* Unable to comply with study questionnaires\n* Ongoing treatment with an investigational drug at inclusion\n* Planned inclusion in another interventional clinical trial within 4 weeks after radiotherapy\n* Patients who are pregnant due to risk of teratogenic and abortifacient effects of radiotherapy","ALL","18 Years",{"count":211,"type":212},200,"ESTIMATED","INTERVENTIONAL",[215],"NA","PALLSOFT is a randomized, open-label, non-inferiority phase III, multicenter, national trial that will investigate whether the patient-reported symptomatic effect of palliative radiotherapy delivered in 1-2 fractions is non-inferior to palliative radiotherapy delivered in five fractions in patients with pelvic soft tissue tumors from either gastrointestinal, urological or gynecological cancer. Health-related quality of life, toxicities, survival and prognostic and predictive biomarkers will be assessed as secondary and explorative endpoints.",[218,219,220],"Gastrointestinal Cancer","Urologic Cancer","Gynecologic Cancer",[20,222,223,224,225,226],"Patient-reported outcomes","Gastrointestinal cancer","Urologic cancer","Gynecologic cancer","Tumor hypoxia","2025-05-22",{"date":229,"type":230},"2025-05-23","ACTUAL",{"date":232,"type":230},"2024-12-10",{"date":234,"type":212},"2030-12",{"name":5,"class":6},11]